Common Contracts
3 similar null contracts by Dianthus Therapeutics, Inc. /DE/
SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
By way of this letter, your Severance Letter Agreement dated April 3, 2023 (the “Severance Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby terminated, and Section 5 of your Offer Letter dated January 20, 2022 (the “Offer Letter”) by and between you and the Company is hereby amended to and restated in its entirety to read as follows:
SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
By way of this letter, Section 5 of your Offer Letter dated October 31, 2021 (the “Offer Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby amended to and restated in its entirety to read as follows:
SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
By way of this letter, Section 5 of your Offer Letter dated January 18, 2022 (the “Offer Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby amended to and restated in its entirety to read as follows:
